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ABSTRACT 
Objective: Oxidative stress appears to be an early event involved in the pathogenesis of Alzheimer's disease (AD). The present study was designed 
to investigate the neuroprotective effects of citrullus lanatus on bilateral common carotid artery occlusion (BCCAO) induced cognitive impairment 
and oxidative stress in Wistar albino rats. 
Methods: Cognitive impairment and oxidative stress were induced by BCCAO for 30 min, followed by 7 d reperfusion of male wistar rats. Morris 
water maze and rectangular maze performance tests and locomotor activity were used to assess memory performance tasks. To study the activity, 
rats weighing 250-300g were pre-treated with successive extracts of n-hexane fraction (HF), ethyl acetate fraction (EAF), ethanol fraction (EF) and 
aqueous fraction (AF) of 400 mg/kg, 200 mg/kg, p. o of each for 10 d and the treatment was continued for another 7 d after cerebral ischemia. 
Various biochemical parameters like lipid peroxidation, Catalase, DPPH and AchE were also estimated in the brain after the treatment. 
Results: There was significantly increased oxidative stress and cholinesterase activity with cognitive decline in the hippocampus in rats of BCCAO 
group as compared to sham-operated (p<0.05). The animals treated with Donepezil, HF and EF prevented the biochemical changes significantly 
(p<0.001) and there was significant (p<0.001) improvement in cognitive parameters compared to BCCAO treated rats. 
Conclusion: Thus present study indicates the neuroprotective effect of citrulus lanatus seed extract (HF and EF) against BCCAO induced cognitive 
impairment and associative oxidative damage. 
Keywords: Antioxidant, Bilateral common carotid artery occlusion, Citrullus lanatus, Cognitive impairment, Oxidative stress 




Alzheimer’s disease (AD) is a one of neurodegenerative disorder, it 
is associated with brain infarction. The characteristic feature of the 
disease is a cholinergic neuronal loss in the hippocampus and frontal 
cortex and is considered to emphasize the cognitive deficit and short 
term memory loss which occur AD. The neuropathological aspect of 
AD includes deposits of extracellular amyloid plaques (Aβ) and 
intraneuronal neurofibrillary tangles [1]. The cause of this disorder 
is multifactorial and oxidative pressure has been reported to play a 
foremost role in the onset and development of AD. In view of the 
mechanistic aspects, it has been predicted that β-amyloid aggregates 
synergistically produce oxidative injury by free radical generation 
[2]. The global cerebral hypoperfusion with bilateral common 
carotid artery occlusion (BCCAO) induced cognitive impairment is a 
well-known model, which may induce BBB disruption, neuronal 
injury in the cortex and hippocampus, cause infarctions in the 
striatum of unstable sizes and elevated inflammatory responses 
since cognitive impairment is central in dementia [3]. This causes 
the death of neurons and related behavioral deficits including 
sensorimotor abnormality, spatial orientation disorder, and 
learning-memory impairments. 
Phytopharmaceuticals are gaining significance as current medicine 
as well as the conventional arrangement of medicine with their 
therapeutic potential. Novel antioxidants may suggest a useful and 
protective means of strengthening the body’s safety against free 
radicals and thus provide defense towards neurodegenerative 
problems. A variety of natural antioxidants like curcumin, 
rosmarinic acid, huperzine A have been shown to have a 
neuroprotective effect against neurodegeneration [4-6]. The 
antioxidants can prevent the oxidation process by interfering with 
free radicals, chelating free catalytic metals and also by acting as 
oxygen scavengers. Recent `studies have revealed that the 
antioxidant mechanisms of plants could be associated with defense 
against oxidative stress and various human diseases like cancer, 
atherosclerosis and the aging process [7, 8].  
Citrullus lanatus (CL) belongs to the family Cucurbitaceae is a 
medicinal plant widely used conventionally in the management of a 
variety of disorders in the world. It has been reported to have 
various pharmacological effects like anthelmintic, anticancer, 
antibacterial, demulcent and diuretic etc. Additionally, a literature 
review reveals the uses CL fruit and have various biological activities 
including anti-oxidants. But seeds are not in generally given 
importance, even though its seed consists of various phytochemical 
components like alkaloids, flavonoids, tannins, amino acids, 
carbohydrates, cardioglycosides, terpenoids, steroids, carotenoids, 
oils and fats [9, 10]. Therefore, the present study was designed to 
investigate the possible In vivo neuroprotective effects of various 
seed extracts of CL against BCCAO induced cognitive impairment 
and associated oxidative damage in rats. 
MATERIALS AND METHODS 
Chemicals and drugs 
Donapezil, Thiopentone sodium, Hydrogen peroxide, povidone-iodine 
powder, 5% w/w (Sri medical and surgical) ethanol, ethyl acetate, n-
hexane (Venkateshwara agencies) Acetylthiocholine iodide (Sigma 
Aldrich), Perchloric acid Formalin 10% (Finar Chemicals), DTNB (5,5-
dithiobis (2-nitrobenzoic acid) reagent, DPPH (1,1-diphenyl-2-
picrylhydrazyl) radical reagent (Sigma Aldrich). 
Plant material 
The fresh watermelons were collected from the local market of 
Warangal district, Telangana state, India. The seeds were separated 
from fruit and shade dried. The collected samples were 
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authenticated morphologically (Voucher specimen no. ENM/SU 
0019022) by Dr. E. Narasimha Murthy, Department of botany, 
Satavahana University, Karimnagar-505002, Telangana state, India. 
Extraction and fractionation method 
The dried seeds of CL were powdered in a blender. This fine powder 
was extracted in a soxhlet apparatus with ethanol for about 36 h. 
The ethanolic extract was cooled, filtered. The filtrate was 
concentrated by using a rotary evaporator under reduced pressure 
till the concentrated mass was obtained. 
The concentrated ethanol extracts were further subjected to partial 
fractionation with solvents of increasing polarity viz. Hexane: Ethyl 
acetate: ethanol: water. Ethanol extracts were dispersed in the non-
polar solvent, Hexane. Hexane dissolved part, which is called hexane 
fraction (HF), it was filtered and concentrated by evaporating the 
solvent under reduced pressure. The remainder thus obtained was 
fractionated subsequently with medium polar solvents such as ethyl 
acetate (EAF) and finally with a polar solvent, water (AF). The 
extracts were analysed by means of thin layer chromatography. 
Experimental animals  
Young male Wistar rats (200-250g) procured from mahaveera 
enterprises, medchal district-98 were used. Animals were adjusted 
to laboratory conditions at room temperature prior to 
experimentation. All the experiments were carried out between 9.00 
AM and 3.00 PM. All animals underwent surgery; they were kept in 
plastic cages with soft bedding under standard conditions of a 12-
hour light/dark cycle with food and water ad libitum. The animal 
experiments were designed as per CPCSEA guideline and protocol of 
the experiments after the authorization of the Institutional Animal 
Ethical Committee (IAEC), Vaagdevi College of Pharmacy, Warangal 
(A. P) and India (1047/PO/Re/S/07/CPCSEA, dated: 21/10/2017). 
Acute toxicity studies 
The acute toxicity of HF, EAF, EF and AF extracts of CL was 
determined as per the OECD guideline no, 423 (acute toxic class 
method). It was observed that these seed extracts were not fatal to 
the rats even at the 2000 mg/kg doses. Hence, 1/5th (400 mg/kg) 
and 1/10th (200 mg/kg) of these doses were selected for further 
studies [11]. 
Groups and treatment 
The Wistar Albino rats (66) of 250-300 gm weight were randomly 
divided into 11 groups of 6 rats each. Vehicle and test substances of 
HF, EAF, EF and AF successive extracts (400, 200 mg/kg of each) of 
CL were prepared freshly and given (p. o.) once daily for 10 
consecutive days prior to the cerebral ischemia. On day 11, 60 min 
after the last dose, all the groups received BCCAO for 30 min 
followed by reperfusion for 7 d. From the second (13) day after 
induction, the animals continued with the test substances for other 
weekdays, then the animals were assessed for behavioral 
parameters. After all behavioral assessments, the brains of different 
groups were removed and assessed for biochemical parameters and 
histopathological evaluation [12]. The detailed treatment schedule is 
as in table 1. 
 
Table 1: Experimental design 
Group number Treatment 
I Sham-operated; 0.1% of CMC in normal saline (10 ml/kg) 
II BCCAO; 0.1% of CMC in normal saline (10 ml/kg) 
III BCCAO+received Donepezil (5 mg/kg) oral 
IV BCCAO+HF (400 mg/kg) orally 
V BCCAO+HF (200 mg/kg) orally 
VI BCCAO+EAF (400 mg/kg) orally 
VII BCCAO+EAF (200 mg/kg) orally 
VIII BCCAO+EF (400 mg/kg) orally 
IX BCCAO+EF (200 mg/kg) orally 
X BCCAO+AF (400 mg/kg) orally 
XI BCCAO+AF (200 mg/kg) orally 
 
Drug administration  
Donepezil (5 mg/kg), the HF, EAF, EF and AF (dissolved in 0.1% 
CMC) of CL were administered at a dose of 400 and 200 mg/kg oral. 
Rats in the sham group and BCCAO group administered solely with 
an equal amount of normal saline. All drugs were prepared freshly 
every day. Doses were given according to the respective rat weights. 
Induction of cerebral ischemia 
BCCAO was used to trigger global cerebral ischemia. Rats were 
sedated with thiopentone sodium at a dose of 50 mg/kg, (i. p). A 
midline opening was made between the neck and sternum and the 
trachea was exposed. Then both the left and right common carotid 
arteries were carefully separated. Cerebral ischemia was induced by 
clamping both of the arteries with two microaneurysmal clips 
(bulldog clamps). The reperfusion of blood through the carotid 
arteries allowed after 30 min of cerebral ischemia by removing both 
the clips. Sham-operated rats underwent the same surgical 
procedure without artery occlusion. During the surgery, the body 
temperature was monitored with a temperature probe and 
maintained at 37.0–37.5 °C using a heating pad [13, 14]. 
Behavioural assessments 
All the animals were trained for 10 d before BCCAO and drug 
administration. 
Spatial navigation task  
The acquisition and retention of a spatial navigation task were assessed 
by using morris water maze [15]. Rats were trained to swim toward a 
visible platform in a circular pool (120 cm in diameter and 60 cm in 
height) located in a test room. In principle, rats can escape from 
swimming by climbing onto the platform and over time the rats have 
apparently learned the spatial location of the platform from any starting 
position at the circumference of the pool. Thus the platform offers no 
local signal to guide the escape behavior of the rats. The pool was filled 
with water (28±2◦C) to a height of 40 cm, a movable circular platform (9 
cm diameter), was placed in a pool 2 cm above the water level during the 
acquisition phase. Similarly, for the maze retention phase, the platform 
was placed in the pool 2 cm below the water level. The water was made 
opaque with a nontoxic dye. Four equally spaced locations around the 
edge of the pool (Q1, Q2, Q3, and Q4) were used as starting points and this 
divided the pool into four equal quadrants.  
Maze acquisition phase (training)  
From the second day after induction, the animals received a training 
session consisting of 4 trials on day 12. In all 4 trials, the starting 
position was different. A trial began by releasing the animal into the 
maze facing towards the wall of the pool. The latency to find the 
escape platform was recorded to a maximum of 90 seconds. If the rat 
did not escape onto the platform within this time, it was guided to 
the platform and was allowed to remain there for 20 seconds. The 
time taken by the rat to reach the platform was taken as the initial 
acquisition latency (IAL).  
Maze retention phase (testing for retention of the learned task) 
Following 24 h (day 13) and 8 d (day 21) after IAL, the rat was released 
randomly from one of the edges facing the wall of the pool. The time is 
taken to find the hidden platform was recorded and termed as first 
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retention latency (1st RL) and second retention latency (2nd RL) on day 
13 and day 21after cerebral ischemia, respectively.  
Assessment of gross behavioral activity  
The gross behavioral activity was observed on days 1, 7 before induction 
and 13, 21 after induction. Animal was placed in a square closed arena 
equipped with infrared light-sensitive photocells using digital 
actophotometer, it consists of photoelectric cells, and they are connected 
with a counter in the circuit. The animals were observed for a period of 5 
min and the values were expressed as counts/5 min [16, 17]. 
Rectangular maze test 
This test was used to evaluate the learning ability. The maze consists 
of a fully enclosed rectangular box with an entry and a reward 
chamber added at opposite ends. The box is partitioned like twisting 
corridor leading into blind passages from the entry to the reward 
chamber with wooden slats. From the second day after induction the 
animals received a training session consisting of 4 trials on day 12. 
In each trial the rat was placed in the entry chamber and the timer 
was activated as soon as the rat leaves the chamber. The time taken 
by the animal to reach the reward chamber from the entry chamber 
was recorded as the initial transfer latency (ITL). The animal was 
allowed to explore the maze for 20 seconds after recording the ITL 
and then returned to the home cage. If the animal did not enter the 
reward chamber within 90 seconds, it was guided on the back to 
reach the reward chamber and the ITL was given as 90 seconds. 
Retention of memory was assessed by placing the rat in an entry 
chamber and the retention latency was noted on day 13 and day 21 
of ITL and was termed as the first retention transfer latency (1st 
RTL) and second retention transfer latency (2nd RTL) respectively. 
Lower scores of the assessment indicate efficient learning while 
higher scores indicate poor learning in animals [18, 19]. 
Dissection and homogenization  
On day 21 after behavioral assessments, animals were sacrificed by 
decapitation prior to deep anesthesia. The brains were removed, 
forebrain was dissected out, and cerebellum was discarded. 
Hippocampus dissected out from the brain and it was put on ice and 
rinsed with ice-cold isotonic saline. A (10% w/v) homogenate was 
prepared with 10 times ice cold 0.1M phosphate buffer (pH 7.4). 
Now the obtained homogenate was centrifuged at 3000rpm for 15 
min and aliquots of supernatant were separated and used for 
biochemical estimation. 
Biochemical tests 
Measurement of lipid peroxidation  
The extent of lipid peroxidation in the brain was determined as 
described by Wills [20]. The amount of malondialdehyde (MDA) was 
measured by reaction with thiobarbituric acid at 532 nm using a 
spectrophotometer. The values were calculated using the molar 
extinction coefficient of chromophore (1.56 × 105 (mol/l) −1 cm−1). 
Catalase activity 
Catalase activity was assessed by the method of Luck [21], wherein 
the breakdown of hydrogen peroxide is measured. Briefly, the assay 
mixture consisted of 3 ml of H2O2 phosphate buffer and 0.05 ml of 
the supernatant of the tissue homogenate. The change in absorbance 
was recorded for 2 min at the 30-second interval at 240 nm using a 
spectrophotometer. The results were expressed as micromoles of 
H2O2 decomposed per minute per mg protein. 
DPPH radical scavenging assay  
The free radical scavenging activity of the test drug was measured in 
vitro by 1, 1-diphenyl-2-picrylhydrazyl (DPPH) assay [22]. In this, 
measurement is made from the bleaching of a purple coloured 
methanol solution of DPPH. To the 1000 L of diverse concentration 
of the homogenate, 4 ml of 0.004% methanolic solution of DPPH was 
added. After 30 min incubation in dark, absorbance was read at 517 
nm. Inhibition of free radical by DPPH in percentage was calculated 
in the following way:  
( ) 100/ ×−≈ AblankAsampleAblankPercentage
 
Ablank: absorbance of control reaction. Asample: absorbance of test 
sample. Values of inhibition were calculated 
Acetylcholinesterase estimation 
Acetylcholinesterase (AChE) is a marker of extensive loss of 
cholinergic neurons in the forebrain. The AChE activity was assessed 
by Ellman method [23]. The change in absorbance was measured for 
2 min at the 30-second interval at 412 nm using a 
spectrophotometer. Results were expressed as micromoles of 
acetylthiocholine iodide hydrolyzed per minute per mg protein. 
Statistical analysis 
Results were expressed in mean±SD. The significance of the 
difference in means between disease control and test drug-treated 
animals for different parameters was evaluated by using One-way 
Analysis of Variance (ANOVA) followed by multiple comparisons 
Dunnett’s test. Data were measured statistically, significant at 
p<0.05 and highly significant at p<0.01. Statistical analysis was 
executed using GraphPad Prism 7 statistical software. 
RESULTS 
Behavioral alteration in rats 
Effect of CL on morris water maze  
Sham-operated, donapezil (5 mg/kg, PO) and CL various extract (HF, 
EAF, EF and AF of 400 and 200 mg/kg, PO) groups of animals 
quickly learned to swim directly to the platform in the morris water 
maze on day 12. BCCAO treated rats showed an initial increase in 
escape latency, which declined with continued training during the 
acquisition of a spatial navigation task on day 12. There was a 
significant difference in the mean IAL of BCCAO treated group 
compared to the sham-operated group on day 12 indicating BCCAO 
induced impaired acquisition of spatial navigation task (P<0.05). In 
contrast, CL various extract (HF, EAF, EF, and AF of 400 and 200 
mg/kg, PO) treatments after cerebral ischemia significantly 
decreased the IAL to reach the platform in the pretrained rats as 
compared to BCCAO treated rats on day 12 (fig. 1). Following 
training, the mean retention latencies (1st and 2nd RL) to escape onto 
the hidden platform were significantly decreased in sham-operated, 
donapezil (5 mg/kg, PO) and CL various extracts (HF, EAF, EF and 
AF of 400 and 200 mg/kg, PO) group rats on days 13 and 21, as 
compared to IAL on day 12 after induction. On the contrary, the 
performance in the BCCAO treated rats was changed after initial 
training in the water maze on days 13 and 21, with the significant 
increase in mean retention latencies compared to IAL on day 12. The 
results suggest that BCCAO caused significant cognitive impairment. 
But the order of mean retention latencies compared to IAL on day 13 
was HF>EF>EAF>AF. However, chronic CL extracts of HF and EF 
starting before induction administration showed a significant 
(P<0.01 and P<0.05 respectively) decline in the 1st and 2nd RL, which 
indicates improved the retention performance of the spatial 
navigation task in both groups in a concentration-dependent 
manner as compared to BCCAO treated rats. 
Effect of CL on the rectangular maze 
In the present experiment, mean ITL on day 12 for each rat was 
relatively stable and showed no significant variation among different 
groups. All the rats entered the reward chamber within 90 seconds. 
Following training, Sham-operated, donapezil (5 mg/kg, PO) and CL 
various extracts (HF, EAF, EF and AF of 400 and 200 mg/kg, PO) rats 
entered the reward chamber quickly as compared to BCCAO treated 
rats. Mean retention transfer latencies (1st RTL and 2nd RTL) to enter 
the reward chamber on days 13 and 21 were shorter as compared to 
ITL on day 12 of each group, respectively. In contrast, BCCAO treated 
rats performed poorly throughout the experiment and did not show 
any change in the mean retention transfer latencies on days 13 and 
21 as compared to pretraining latency on day 12, demonstrating that 
BCCAO induced marked memory impairment. Chronic 
administration of CL various extracts (HF, EAF, EF and AF of 400 and 
200 mg/kg, PO) beginning prior to cerebral ischemia significantly 
decreased the mean retention latencies on days 13 and 21 after 
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cerebral ischemia. The mean transfer latencies of CL extracts of HF and 
EF were significantly decreased in a concentration-dependent manner 
on days 13 and 21 (P<0.01 and P<0.05 respectively) than CL of EAF 
and AF extracts when compared to the BCCAO treated group (fig. 2) 
 
 
Fig. 1: Effect of Donepezil, CL of HF, EAF, EF and AF successive extracts on spatial navigation task compared to the BCCAO group, values are 
expressed as mean±SD (n = 6); *p<0.05, ** p<0.01 as compared with corresponding values of BCCAO group. (One way ANOVA followed by 
dunnett’s test) 
 
Fig. 2: Effect of Donepezil, CL of HF, EAF, EF and AF successive extracts on memory performance in rectangular maze compared to the 
BCCAO group, values are expressed as mean±SD (n = 6); *p<0.05, ** p<0.01 as compared with corresponding values of BCCAO group. (One 
way ANOVA followed by dunnett’s test) 
 
Effect of CL on locomotor activity 
The mean scores of locomotor activity for each rat were showed 
significant variation among different groups. The mean scores in 
sham-operated, donapezil (5 mg/kg, PO) and CL various extracts 
(HF, EAF, EF and AF of 400 and 200 mg/kg, PO) rats cause 
significant increase in locomotor activity compared to BCCAO 
treated rats on days 13 and 21 as compared to pretraining 
locomotor activity on day 1 and 7 in concentration-dependent 
manner. More significant (P<0.05 and P<0.01, respectively) increase 
in locomotory activity was seen in CL extracts of HF and EF rats, 
when compared to CL extract of EAF and AF, treated rats (fig. 3). 
Antioxidant effect of citrulus lanatus on BCCAO induced rats 
Cerebral ischemia followed by reperfusion caused a significant rise 
in brain MDA levels and depletion of CAT, DPPH levels in BCCAO 
treated animals as compared to sham-operated animals. However, 
chronic CL extracts HF, EF (400 and 200 mg/kg, PO) treatment 
significantly (P<0.01) attenuated the increase in MDA levels and also 
caused a significant (P<0.01) increase in CAT and DPPH levels when 
compared to the BCCAO treated rats. Whereas there were no 
significant differences were observed in EAF and AF treated animals 
(table 2). 
Brain acetylcholine levels by citrulus lanatus on BCCAO induced 
rats 
BCCAO followed by reperfusion showed a significant increase in the 
brain AchE activity as compared to sham-operated rats. However, 
chronic CL extracts HF, EF (400 and 200 mg/kg, PO) treatment 
significantly (P<0.01) attenuated enhanced AchE activity compared 
to BCCAO treated rats. (table 2) but there were no significant 
differences were observed in EAF and AF treated animals. 
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Fig. 3: Effect of donepezil, CL of HF, EAF, EF and HEF successive extracts on locomotor activity compared to the BCCAO group, values are 




Fig. 4: Histopathological representative photographs (H and E stain) of hippocampal brain sections, (A) sham operated (B) BCCAO treated 
(C) Donapezil (D, E, F, G) citrulus lanatus extracts of HF, EAF, EF and AF 400 mg/kg treated ischemic groups respectively, which were 
observed under 40X magnification [inflammatory infiltration (I), Necrosis (N), shrinkage (S) vacuolization (V)] 
 
Histopathological results 
From the fig. 4 histopathological study, it was observed that 30 
min of BCCAO followed by 7 d reperfusion produced shrinkage, 
atrophy and necrosis of neurons along with the vacuolization and 
inflammatory infiltration in the hippocampal regions of disease 
control animals when compared with normal control animals. The 
reactive changes were significantly attenuated in the HF, EF and 
donapezil pretreated animals as compared to disease control 
animals. However, no significant changes were observed in the 
EAF and AF treated animals when compared to disease control 
animals. 
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Table 2: Effect of donapezil, CL seed HF, EAF, EF and AF successive extracts on BCCAO induced alteration in animals brain MDA, CAT, DPPH 
and AchE levels 
Treatment (mg/kg) MDA (nmol/g tissue) CAT(µmol of H2O2 min/mg 
tissue) 




Sham operated 15.26±1.30 11.2±0.5 65.31±1.20 7.92±1.3 
BCCAO treated 30.15±1.56 4.15±1.2 25.13±1.20 17.22±2.4 
Donapezil-5 16.59±3.60*** 9.11±1.8*** 48.9±2.6*** 7.24±4.1*** 
HF–400 17.60±2.70*** 8.0±0.7*** 45.21±2.80*** 7.34±2.31*** 
HF–200 18.1±3.1*** 7.6±0.5*** 40.18±1.30** 6.9±1.3*** 
EAF–400 27.6±4.2 4.1±1.9 25.12±4.10 17.6±1.6 
EAF–200 28.1±5.6 4.6±1.3 23.21±3.10 17.89±2.3 
EF–400 20.65±4.20** 7.6±1.5*** 45.31±2.50** 11.6±2.1** 
EF–200 21.1±3.2** 6.9±1.3** 39.18±4.10* 13.9±1.5* 
AF–400 29.1±1.2 4.5±2.1 24.01±2.20 17.8±2.6 
AF–200 28.6±6.6 3.9±1.6 22.09±1.30 17.9±1.3 
Values are expressed as mean±SD (n=6) *p<0.05, ** p<0.01, *** p<0.001 as compared with corresponding values of disease control group (one way 
ANOVA followed by dunnett’s test). 
 
DISCUSSION 
Cerebral ischemic injury induced by BCCAO induces transient 
metabolic changes in various brain regions. Reperfusion injury 
results when cell damage induced by ischemia is heightened by post-
ischemic reperfusion. Restoration of blood flow to an ischemic brain 
region is associated with the generation of reactive oxygen species 
with consequent reperfusion injury [24]. BCCAO for 30 min followed 
by reperfusion was associated with increased generation of reactive 
oxygen species [25]. 
The principal finding of the present study is that the cerebral 
ischemic reperfusion injury was associated with oxidative stress, as 
evidenced by an increase in brain AchE, MDA levels and depletion of 
cerebral endogenous antioxidants like CAT, DPPH activities in 
BCCAO treated rats. Similar observations made earlier by other 
studies [26, 27]. Increased levels of MDA reflect the membrane 
damage induced by toxic lipid peroxidation products. The depletion 
in CAT and DPPH enzymes was observed and taken as a marker of 
oxidative stress. In present study indicating that the administration 
of CL extracts prevented the oxidative stress and the biochemical 
changes associated with cerebral ischemic reperfusion injury. The 
mechanism of such protection of oral administration of CL extracts 
may be due to cerebral adaptation, through augmentation of cellular 
antioxidants such as DPPH and CAT. In cerebral ischemic 
reperfusion damage, oxidative stress plays a major role in its 
etiopathogenesis. Protection against oxidative stress through this 
mechanism may be one of the effective therapeutic approaches. 
Oxidative stress is believed to be a central source for the generation of 
post cerebral ischemic injury. Various experimental models of cerebral 
ischemic reperfusion injury showed significant neuroprotection when 
treated with antioxidants [28]. Recent survey has shown that many 
dietary polyphenolic components derived from plants are more 
effective antioxidants In vitro than vitamins E or C, and thus might 
contribute significantly to the protective effects in vivo [29]. 
There is extensive evidence which supports the antioxidant activity 
of CL seed extracts and the potency of anti-oxidant activities 
depending on the type of extract [30]. Augmentation of endogenous 
antioxidants by therapeutic substances has recently evoked 
scientific interest because any such property of a therapeutic agent 
can be expected to cause a significant improvement in the 
endogenous defense against oxidative stress. [31] The observed 
beneficial effects of CL extracts on cerebral ischemic reperfusion 
injury-induced changes in biochemical parameters may thus be 
attributed to its various chemical constituents. BCCAO produces 
marked destruction of hippocampal granule cells, resulting in loss of 
cholinergic neurons with a significant increase in AchE activity 
thereby leading to learning and memory deficits.  
In the present study, BCCAO treated rats showed significant memory 
impairment in water maze and rectangular maze tasks which were 
attenuated by CL treatement. Major findings of this study are that 
Chronic administration of CL various extracts (HF, EAF, EF and AF of 
400 and 200 mg/kg, PO) beginning prior to cerebral ischemia was able 
to improve the cognitive deficit and attenuated oxidative stress, 
suggesting that CL improves cognitive task and has antioxidant like 
effect. CL extracts of HF and EF more significantly improved the 
cognitive functions and ameliorates the BCCAO induced decrease in 
AchE activity than extracts of EAF and AF when compared to the 
BCCAO treated animals. 
CONCLUSION 
The present study suggests that chronic administration of CL 
extracts of HF and EF prevents BCCAO induced cognitive 
impairment and associated oxidative stress. Thus, the use of CL 
extracts of HF and EF is promising for the treatment of AD and other 
neurodegenerative disorders. 
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